STONKWHISPER
← Back to Intel
Insider ActivityNRIX

van Houte Hans, Chief Financial Officer at Nurix Therapeutics, Inc., sold $223K of NRIX

Updated Jun 13, 2026
van Houte Hans Chief Financial Officer
Nurix Therapeutics, Inc. · $NRIX
$223K Total Value
13,473 Shares Traded
$16.5756 Price / Share
38,174 Shares Owned After
2026-05-05 Filing Date

Transaction Details

Insidervan Houte Hans
TitleChief Financial Officer
CompanyNurix Therapeutics, Inc.
TickerNRIX
Transaction TypeSale
Transaction Date2026-05-05
Shares Traded13,473
Price Per Share$16.5756
Total Value$223K
Filed Date2026-05-05
Accession Number0001817217-26-000008

Ownership Context

Shares Owned After Transaction38,174
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001817217-26-000008

Other Insider Trades — NRIX

Other Trades by van Houte Hans

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for NRIX — Nurix Therapeutics, Inc. →

Track NRIX insider activity in real time on The Wire →

Get alerts when van Houte Hans files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 13, 2026 at 07:12 UTC

Want real-time data? Access The Wire for live sentiment tracking.